↓ Skip to main content

Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302

Overview of attention for article published in Cancer & Metabolism, January 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter
5 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302
Published in
Cancer & Metabolism, January 2015
DOI 10.1186/s40170-014-0026-z
Pubmed ID
Authors

Jonathan W Wojtkowiak, Heather C Cornnell, Shingo Matsumoto, Keita Saito, Yoichi Takakusagi, Prasanta Dutta, Munju Kim, Xiaomeng Zhang, Rafael Leos, Kate M Bailey, Gary Martinez, Mark C Lloyd, Craig Weber, James B Mitchell, Ronald M Lynch, Amanda F Baker, Robert A Gatenby, Katarzyna A Rejniak, Charles Hart, Murali C Krishna, Robert J Gillies

Abstract

Hypoxic niches in solid tumors harbor therapy-resistant cells. Hypoxia-activated prodrugs (HAPs) have been designed to overcome this resistance and, to date, have begun to show clinical efficacy. However, clinical HAPs activity could be improved. In this study, we sought to identify non-pharmacological methods to acutely exacerbate tumor hypoxia to increase TH-302 activity in pancreatic ductal adenocarcinoma (PDAC) tumor models.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 4%
Japan 1 1%
Unknown 63 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 18%
Researcher 11 16%
Other 7 10%
Student > Postgraduate 6 9%
Professor > Associate Professor 6 9%
Other 11 16%
Unknown 14 21%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 19%
Medicine and Dentistry 12 18%
Agricultural and Biological Sciences 10 15%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Engineering 2 3%
Other 8 12%
Unknown 20 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 November 2023.
All research outputs
#6,461,354
of 25,775,807 outputs
Outputs from Cancer & Metabolism
#75
of 231 outputs
Outputs of similar age
#79,598
of 363,792 outputs
Outputs of similar age from Cancer & Metabolism
#2
of 3 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 231 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,792 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.